| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $408.0M | -13.6% | +143.4% |
| Cost of Revenue | $309.3M | -16.1% | +196.1% |
| Gross Profit | $98.8M | -5.1% | +56.3% |
| R&D Expense | $27.1M | -24.7% | +20.5% |
| SG&A Expense | $99.4M | +1.1% | +127.0% |
| Operating Income | -$268.4M | -788.2% | -8595.8% |
| Pre-tax Income | -$265.1M |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $289.9M | -19.4% | +516.8% |
| Short-term Investments | $297.3M | +29.8% | — |
| Accounts Receivable | $201.0M | -13.5% | +147.5% |
| Inventory | $299.3M | +15.5% | +102.3% |
| Current Assets | $1.70B | +2.3% | +213.3% |
| Total Assets |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$173.9M | — | — |
| Capital Expenditures | $46.1M | — | — |
| Investing Cash Flow | -$1.22B | — | — |
| Financing Cash Flow | $1.65B | — | — |
| Free Cash Flow | -$220.1M | — | — |
| -1186.9% |
| — |
| Income Tax | -$21.6M | -837.8% | -3472.9% |
| Net Income | -$243.8M | -1325.6% | — |
| EPS (Basic) | -$4.90 | -1341.2% | -8066.7% |
| EPS (Diluted) | -$4.90 | -1341.2% | -8066.7% |
| $5.36B |
| -4.9% |
| +411.8% |
| Current Liabilities | $309.3M | -5.7% | +140.0% |
| Long-term Debt | $747.5M | +0.0% | +2890.0% |
| Stockholders' Equity | $4.18B | -5.3% | +386.0% |